Cardiovascular health study (CHS) task area b, biorepository-based research projects
Ended Awarded Last action
- Contract number
- 75N92021F00002
- Awardee
-
University Of Washington UEI HD1WMN6945W6 Part of University Of Washington
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $674,371
Award facts
- Contract value 100% obligated
- $674,371.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Seattle, WA 98195, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $674,371 |
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order to the University of Washington's Office of Sponsored Programs for Task Area B of the Cardiovascular Health Study (CHS) Biorepository-Based Research Projects. This cost-no-fee contract, valued at $674,371, supports biorepository-based research initiatives critical to the NHLBI's mission of advancing cardiovascular and pulmonary health through scientific investigation. The contract was originally awarded on April 1, 2021, with an ultimate completion date of March 31, 2024. This award represents a non-set-aside contract, demonstrating the University of Washington's competitive capability to secure significant federal research funding. The work will be performed in Seattle, Washington.
As a child contract under the parent University of Washington entity, this award leverages the institution's extensive research infrastructure and expertise in biomedical research and data management. The University of Washington has established itself as a key federal research partner, successfully competing for contracts across multiple agencies including the National Institutes of Health, Department of Veterans Affairs, and the Defense Advanced Research Projects Agency. The CHS biorepository work aligns with the NHLBI's broader research portfolio, which focuses on understanding cardiovascular disease mechanisms and developing evidence-based interventions to improve public health outcomes.
Quick answers
Who was awarded contract 75N92021F00002?
75N92021F00002 was awarded to University Of Washington by National Heart Lung and Blood Institute (National Institutes of Health) on April 1, 2021.
How much is contract 75N92021F00002 worth?
The government has obligated $674,371 on 75N92021F00002.
Is contract 75N92021F00002 an order under another contract?
Yes. 75N92021F00002 is a delivery order under 75N92021D00006, an indefinite delivery contract.
Was contract 75N92021F00002 competed?
The extent of competition for 75N92021F00002 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award